Crizotinib

glutamic--pyruvic transaminase ; Homo sapiens







6 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34915469 Crizotinib versus Alectinib for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. 2022 1
2 35155225 An Insight on the Pathways Involved in Crizotinib and Sunitinib Induced Hepatotoxicity in HepG2 Cells and Animal Model. 2022 1
3 30642448 Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing. 2019 Feb 1
4 26898609 Crizotinib-induced fatal fulminant liver failure. 2016 Mar 1
5 25239305 The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: a meta-analysis of clinical trials. 2014 Sep 19 1
6 23386065 Crizotinib: a new treatment option for ALK-positive non-small cell lung cancer. 2013 Feb 1